International Biotechnology Trust’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$6.93M Hold
51,914
2.34% 17
2023
Q2
$9.46M Buy
51,914
+24,672
+91% +$4.5M 2.88% 12
2023
Q1
$6.16M Sell
27,242
-20,560
-43% -$4.65M 1.72% 20
2022
Q4
$9.4M Buy
47,802
+22,102
+86% +$4.34M 2.9% 10
2022
Q3
$4.77M Buy
25,700
+16,602
+182% +$3.08M 1.53% 21
2022
Q2
$48K Sell
9,098
-40,246
-82% -$212K 0.5% 44
2022
Q1
$10.8M Buy
49,344
+10,794
+28% +$2.35M 2.43% 16
2021
Q4
$14.3M Buy
38,550
+10,794
+39% +$3.99M 3.18% 11
2021
Q3
$10.9M Buy
+27,756
New +$10.9M 2.64% 12
2021
Q2
Sell
-16,756
Closed -$6.26M 69
2021
Q1
$6.26M Buy
+16,756
New +$6.26M 1.66% 20
2020
Q1
Sell
-25,803
Closed -$8.32M 59
2019
Q4
$8.32M Hold
25,803
3% 12
2019
Q3
$7.64M Hold
25,803
3.53% 10
2019
Q2
$9.24M Hold
25,803
3.43% 11
2019
Q1
$7.8M Sell
25,803
-8,738
-25% -$2.64M 2.88% 11
2018
Q4
$7.92M Sell
34,541
-18,504
-35% -$4.24M 4.91% 7
2018
Q3
$14.5M Buy
53,045
+6,785
+15% +$1.86M 6.9% 2
2018
Q2
$12.6M Buy
+46,260
New +$12.6M 4.83% 4
2017
Q3
Sell
-14,023
Closed -$2.37M 57
2017
Q2
$2.37M Sell
14,023
-45,232
-76% -$7.63M 0.9% 34
2017
Q1
$9.84M Buy
59,255
+1,748
+3% +$290K 3.77% 9
2016
Q4
$7.16M Buy
+57,507
New +$7.16M 3.23% 13